Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 1999, p. 2776-2779, Vol. 43, No. 11
Department of Microbiology,
Received 11 February 1999/Returned for modification 31 May
1999/Accepted 29 August 1999
Using checkerboard and time-kill assays, we evaluated the in vitro
activity of quinupristin-dalfopristin (RP 59500) alone and in
combination with five other antimicrobial agents against 12 clinical
strains of vancomycin-resistant Enterococcus faecium (VREF). In time-kill studies, six VREF strains exhibited synergism with
the combination of quinupristin-dalfopristin and doxycycline and three
exhibited synergism with quinupristin-dalfopristin plus ampicillin-sulbactam. Combinations of quinupristin-dalfopristin with
these and other agents warrant further clinical evaluation for the
treatment of serious VREF infections.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Synergy Testing of Vancomycin-Resistant Enterococcus
faecium against Quinupristin-Dalfopristin in Combination with
Other Antimicrobial Agents
*
Corresponding author. Mailing address: Department of
Microbiology, Sunnybrook and Women's College Health Sciences Centre, B121-2075 Bayview Ave., North York, Ontario, Canada M4N 3M5. Phone: (416) 480-4549. Fax: (416) 480-6845. E-mail:
andrew.simor{at}sunnybrook.on.ca.
Antimicrobial Agents and Chemotherapy, November 1999, p. 2776-2779, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»